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ABSTRACT 
 
 Compounds containing the tetrazole scaffold have wide variety of 
applications in medicine, food industry, automobile industry, photography, 
agriculture. As a result, the structure and reactivity of these compounds have 
been studied. However, the related tetrazolethione scaffold has not been studied 
well. In our work presented in Chapter-1 (part-1), the synthesis, photochemical 
properties and reactivities of 1,4-disubstituted tetrazolethione analogs 20a-d are 
described.  The solvent effects on the photochemistry of compounds are 
discussed and; the rates and quantum yields for the photodecomposition of 
compounds are documented. The photodecomposition products for the 
photolysis of 20a-d were analyzed by LCMS, GCMS and NMR spectroscopy; the 
results pertaining to their identification are also reported. Further, the multiphoton 
excitation of THF solution of1-methyl-4-(4-nitrophenyl)-1H-tetrazol-5(4H)-thione 
20d with Ti: Sapphire laser was also performed; however, the experiment was 
not successful. In Chapter-2 (part-1), the cytoxicity of the 1-methyl-4-(4-
chlorophenyl)-1H-tetrazol-5(4H)-thione 20c against human breast cancer cell is 
documented. MTT assays were performed for a time dependent study of the 
cytoxicity.  
 
 In part-2 which consists of Chapter-3, the synthesis of 2-(2-
phenylimino)vinyl)benzonitirle is described. This was as a step towards our 
laboratory’s goal of synthesizing a series of mono-, di- and tri- azaenyne-allenes 
and studying their Myers-Saito and Schmittel cyclizations. In future, if our 
cyclization studies are successful, these cyclizations could be employed for 
synthesis of heteroaromatic rings found in many compounds of biological 
importance. 
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CHAPTER 1 
Photochemistry of 1,4-Disubstituted Tetrazolethiones 
 
I. INTRODUCTION 
I. 1. Enediynes 
Naturally occurring enediyne compounds form a class of very potent 
antitumor antibiotics. Neocarzinostatin (NCS) was the first enediyne to be 
isolated from Streptomyces carzinostaticus in 1965 (Scheme 1).1 Since then, 
many enediynes have been discovered (e.g. calicheamicin r1, Scheme 1).  
These compounds are divided into two groups based on the 9- or 10- membered 
ring structure.2  
              
Scheme 1. Naturally occurring antitumor antibiotics enediynes.2 
 
In 1972, Bergman showed with the help of model compounds that 
enediynes undergo thermally triggered cycloaromatization reaction to 1, 4- 
benzenoid biradical which abstracts hydrogens from the hydrogen donors 
(Scheme 2).3 This cycloaromatization is known as Bergman cyclization and is 
thought to be responsible for the biological activity of these compounds. 
 3 
 
                                        Scheme 2. Bergman Cyclization.3 
 
It is well known that naturally occurring antitumor antibiotics enediynes 
consist of a chromophore which may or may not be associated with an 
apoprotein.2 The apoprotein binds non- covalently to the chromophore and 
stabilizes it. In addition, this apoprotein delivers the chromophore into the minor 
groove of target cell’s DNA where enediyne functionality of the chromophore is 
activated through Bergman cyclization as discussed above, (Scheme 2) to form 
the 1, 4- benzenoid biradical. This biradical is well placed to abstract the 
hydrogen atoms from the adjacent strands of DNA and cause scission of the 
DNA double helix.3,4 It is this understanding of structure and mechanism of action 
of naturally occurring enediyne based compounds that revolutionalized the 
development of anticancer drugs in 1980s.  
NCS also consists of 1:1 noncovalently associated mixture of an 
apoprotein and the chromophore, however, follows slightly different path to 
cleave DNA. The mechanism of DNA cleavage by NCS 1 is shown in Scheme 3. 
This mechanism was proposed by Myers in 1987.5 The enediyne moiety goes 
 4 
through a cascade of reactions to generate biradical which is discussed as 
follows.  
 
                         Scheme 3. Mechanism of action of Neocarzinostatin Chromophore. 4, 5 
 
The cyclization process is initiated by the stereospecific attack of thiol on 
C-12 of NCS. This leads to the rearrangement of the ring skeleton followed by 
opening of epoxide ring. As a result a cumulene intermediate 2 is formed which 
undergoes Myers- Saito cyclization to generate the biradical 3 which then 
abstracts hydrogen atoms from the sugar phosphate backbone of DNA and 
ultimately, leads to strand scission (Scheme 3)4, 5. The mechanism of DNA 
 5 
strand scission is illustrated in Scheme 4.  The generation of a radical on the 
DNA backbone is followed by the addition of molecular oxygen to form a 
hydroperoxide which then undergo reduction followed by the formation of 
aldehyde products as shown. 4   
 
                 
Scheme 4. Mechanism of DNA cleavage by enediynes via C (5)’ hydrogen 
abstraction.4 
 
The biradical in case of neocarzinostatin primarily attacks the adenine and 
thymine rich sites; this leads to single strand cleavage of DNA. Approximately 
80% of the cleavage is caused as a result of attack of the C-6 radical of 
neocarzinostatin on the C-5’ of deoxyribose sugar leading to formation of 5’- 
aldehydes of adenine and thymine.4 Less than 20% of the cleavage is caused 
 6 
due to double strand lesions, this requires additional abstraction of hydrogen by 
C-2 radical of NCS from the C-1’ or C-4’ of deoxyribose sugar present on the 
complementary strand.  
 
I. 2. Enyne- Allenes and Hetero- Allenes 
Over years many naturally occurring enediynes have been discovered; 
however, the non- specificity limits their use as anticancer drugs.6-9 Since the 
discovery of enediynes, scientists have been working towards the development 
of new drugs which would mimic these drugs in their mode of action but would 
have fewer side effects. One class of drugs that is inspired by enediynes is 
enyne-allenes 5. These compounds are known to undergo thermal and 
photochemical cyclization via two different pathways, the C2- C7 or Myers–Saito 
cyclization and the C2-C6 or Schmittel cyclization.10-14 The Schmittel pathway is 
favored when a bulky group (R=  Ph or t- Bu) is present at the alkyne end of the 
enyne-allenes.15 The two cyclizations yield α, 3- dehydrotoluene 7 and fulvene-
like biradicals 6, respectively. The biradicals (6 and 7) are known to abstract 
hydrogen from the hydrogen donors like 1, 4- cyclohexadiene.11, 15 The 
experiments have also shown that the generated biradicals mimic enediynes by 
cleaving DNA via hydrogen abstraction from the sugar phosphate backbone.16, 
17(Scheme 5) 
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                      Scheme 5. Myers- Saito and Schmittel cyclization in enyne- allenes. 
 
Similarly, hetero-allene based compounds have been synthesized. 
Replacement of one or two carbons in allene functionality of enyne-allenes gives 
rise to enyne ketenimines and enyne carbodiimides, respectively (Scheme 6). 
These compounds also undergo Myers- Saito and Schmittel cyclizations under 
thermal conditions to generate α, 3- dehydrotoluene and fulvene- like biradicals 
that are known to abstract hydrogen from 1, 4- cyclohexadiene (1,4-CHD), 
analogous to enyne-allenes 5.18- 21  Under photochemical conditions, only the 
Schmittel product is observed, irrespective of the substituent present on the 
alkyne terminus.  However, it is not known if these compounds abstract hydrogen 
from deoxyribose of the sugar phosphate backbone of DNA and cause cleavage. 
One big drawback related to enyne carbodiimides or enyne-keteneimines is that 
they are highly reactive due to the presence of carbodiimide or keteneimine 
moiety which renders them susceptible to biological nucleophiles. This maybe 
the reason that no DNA cleaving studies related to these compounds have been 
reported so far.  Evidently, in order to use these compounds as drugs one has to 
 8 
protect the respective carbodiimide or the keteneimine functionality from 
biological nucleophiles.  This may be achieved by masking these functionalities 
in a structure that could be easily unmasked photochemically, once the drug is 
localized in the target cell.    
                                         
                                                   
                                   Scheme 6. Enyne Ketenimine and Enyne Carbodiimide 
 
I. 3. Chemotherapeutive Drugs Based on Enyne-Carbodiimides 
The objective of our research group is to develop chemotherapeutive 
drugs based on enyne-carbodiimides.  In order to achieve this goal, we plan to 
develop masked enyne-carbodiimides 8 as prodrugs where the carbodiimide 
functionality will be protected in a tetrazolethione ring structure.  Once absorbed 
in the body, 8 will be locally irradiated in cancer cells by an infrared laser through 
multiphoton excitation, to generate 9, that is immediately expected to undergo 
cyclization to give 10 which will cause DNA strand scission leading to cell death. 
 
 
                  Scheme 7. Generation of active carbodiimide drug and DNA Cleavage 
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I. 4.   Previous Studies on the Photodecomposition of Tetrazolethiones 
and the Challenges to be Addressed 
Quast and co-workers have reported that the photochemical 
decomposition of 1, 4-disubstituted tetrazolethiones 11 occur with the formation 
of carbodiimides 12, and simultaneous expulsion of dinitrogen and molecular 
sulfur (Scheme 8)22-24.    
                     
                         
                     Scheme 8. Photochemical decomposition of tetrazolethione compounds.  
 
 The photochemistry of tetrazolethiones has been revisited by Fausto and 
coworkers who reported that the photochemical decomposition 1-methyl-1H-
tetrazole-5(4H)-thione, a monosubstituted tetrazolethione, occurs with the 
formation of a variety of products in addition to carbodiimides, via three 
decomposition pathways involving (1) the expulsion of dinitrogen to form 1-
methyl-1H-diazirene-3-thiol, (2) the cleavage of the tetrazolethione ring to form 
methylisothiocyanate and azide, and (3) the concurrent expulsion of dinitrogen 
and sulfur to form N-methyl carbodiimide(Scheme 9).46   
 10 
          
Scheme 9. Photochemical decomposition of 1-methyl-1H-tetrazole-5(4H)-thione.46 
 
 The authors also reported that the primary photoproducts undergo further 
reactions in the gas phase to form secondary photoproducts such as methyl 
diazene, carbon monosulfide and nitrogen hydride.  Analogous to the 
monosubstituted tetrazolethione, the photodecomposition of 1,4-disubstituted 
tetrazole-5-thiones may also proceed with the formation of the products other 
than the carbodiimide as initially reported by Quast.  No studies have been 
reported on the rate of the photodecomposition of tetrazolethiones to 
carbodiimides, their yields or the overall efficiencies of this conversion.  The 
ability to drive the photodecomposition in the direction of “carbodiimide” is critical 
to accomplishment of our goal. Therefore, before the synthesis of prodrug (give 
number) could begun, the photochemistry of tetrazolethiones needs to be 
thoroughly investigated.   
 11 
Secondly, the photochemical studies by Quast and Fausto have employed 
UV light at which the living cells are vulnerable to photodamage.  In order to 
exploit this chemistry for activation of prodrug 8 (Scheme 7), in vivo, one needs 
to be able to use longer wavelength that will not damage the living cells.  
Therefore, we will use multiphoton excitation to convert tetrazolethiones to 
carbodiimides.  This technique allows one to excite the UV absorbing 
chromophores by a laser in the 800-900nm range.  This is important because 
cells are commonly transparent at 870 nm, but strongly absorbing at < 300 nm.  
The biological applications of multiphoton excitation have been well-documented 
in literature.49, 50 Note that the conversion of a tetrazolethione ring to carbodiimide 
has not been studied under multiphoton excitation and needs to be established 
before the synthesis of prodrug 8 could commence.  
We wanted to first investigate the photochemistry of the tetrazolethione 
ring via single photon excitation so that the information collected from the 
experiments could be employed to design the experimental conditions for the 
multiphoton excitation studies. Thus, our first goal was to synthesize four 
differently substituted 1, 4- disubstituted tetrazolethione analogs 20a-d (Scheme 
10) and to study the effect of substituents on photostability and photoliability of 
the tetrazolethione ring.  
                                         
                                               
                                                Scheme 10. 1, 4- disubstituted tetrazolethiones 
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I. 5.  Our approach 
Since the nature of the substituents is known to affect the photochemical 
properties of the tetrazolethione ring,25- 28  our goal is to synthesize a series of 
different 1-methyl-4-phenyl tetrazolethiones substituted with a variety of different 
electron-withdrawing or electron-donating groups at the phenyl ring and study 
their photophysical and photochemical properties.  These studies will allow us to 
identify systems that will give the high yields of carbodiimides as well as show 
high rates of photodecomposition and quantum efficiencies upon UV irradiation.  
Once we have a better understanding of the tetrazolethione photochemistry 
under single-photon excitation, we will study the conversion of select 
tetrazolethiones to carbodiimides under multiphoton excitation. 
Therefore, with this goal in mind, we synthesized four analogs of 1-methyl-
4-phenyl tetrazolethiones 20a with three different substituents at the phenyl ring 
20b - c.  The substituents were; OMe group with strongly activating effect, Cl with 
weakly deactivating effect and NO2 having the strongly deactivating effect.  The 
photochemistry of these compounds was studied in THF and MeCN to 
investigate the effect of solvent polarity on the photochemical properties of the 
tetrazolethione system. The product mixtures were analyzed using LCMS and 
EI/GCMS.  
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II.   RESULTS AND DISCUSSION 
II. 1. Synthesis of 1, 4- disubstituted tetrazolethione 20a- d 
 Synthesis was carried out as follows. The literature reported procedures 
were followed for synthesis our tetrazolethione analogs (Scheme 11) and all 
products were analyzed by 1H-NMR, 13C-NMR and mass spectroscopy. 
5-chloro-1- phenyl- 1H- tetrazole 22 was formed via 1, 3–dipolar 
cycloaddition of phenyl-1, 1-dichloroisocyanide 21 and sodium azide in the 
presence of tetrabutylammonium bromide in water-toluene suspension.29 The 
reaction was carried out at room temperature for 2.5 h and yielded 22 in 73% 
yield. 22 was refluxed at 70oC for 2 h in NaOH/ ethanol which resulted in the 
formation of 1-phenyl-1H- tetrazol-5(4H)-one 23a in 95% yield.30 Nitration of 23a 
with fuming HNO3 at 100oC for 30 min gave 1-(4-nitrophenyl)-1H-tetrazol-5(4H)-
one 23d in 59% yield.30 Remaining two tetrazolone analogs, 1-(4-
methoxyphenyl)-1H-tetrazol-5(4H)-one 23b and 1-(4-chlorophenyl)-1H-tetrazol-
5(4H)-one 23c were synthesized from their corresponding isocyanates 24b-c by 
refluxing in neat trisilylazide (TMSA) under N2 for 24 h at 100oC.31 23b was 
produced in 90% yield and 23c was produced in 95% yield.  
 14 
                                    
Scheme 11. Key: (i) NaN3, Bu4NBr, toluene, r.t., 2.5 h; (ii) 10% NaOH, ethanol, 70oC, 2 h; (iii) 
fuming HNO3, 100oC, 30 min; (iv) Me3SiN3, 100oC, 24h; (v) Me2SO4/ CH2Cl2, Bu4NBr, 10% 
NaOH/ CH2Cl2, r.t., 3h; (vi) thionation. 
              
 Methylation of 23a-d with Me2SO4 in dichloromethane yielded the 
respective 1, 4-disubstituted tetrazolones 25a-d. 23a-d were stirred at room 
temperature with Me2SO4 in dichloromethane in the presence of 10% NaOH and 
Bu4NBr for 3 h.32 25a was produced in 84%, 25b  in 92%, 25c in 90% and 25d in 
96% yield. After Synthesis of 1, 4-disubstituted tetrazolones 25a-d was 
accomplished, the last step involving thionation of these compounds remained 
(Scheme 11).   We first tried this reaction for 1-methyl-4-phenyl-1H- tetrazol-
5(4H)-one 20a. 25a was first refluxed with P2S5 in dry pyridine under N2 at 
115.5oC.33 Even after 4 days, the desired starting material 25a was found 
unreacted. Therefore, we tried several other methods to synthesize the final 
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products 20a – d.   First, we attempted the synthesis of 20a according to the 
method reported by Quast. According to this procedure, 25a was refluxed with 
P2S5 in dry toluene under N2 at 110oC.22 After 4 days, the desired product 20a 
was obtained in 55% yield. Since the reaction took 4 days, we searched the 
literature for other methods requiring shorter reaction times.  We tried the 
thionation of 25a with Lawesson’s reagent (Scheme 12) in dry toluene under N2 
at 110oC.34 Even after 4 days of refluxing, desired product was not obtained. We 
also tried refluxing 25a and Lawesson’s reagent in dry pyridine but our attempt 
was still unsuccessful.  
                                               
                                                       Scheme 12 . Lawesson’s reagent 
 
In our next attempt, we decided to synthesis 20a by another method that 
involved first generating the monosubstituted tetrazolethione from 22 and then 
attempting methylation37 as shown in Scheme 13. 
   
                     
Scheme 13.  Synthesis of 20a. (i) thiourea, ethanol, 80oC, 4 days; (ii) NEt3, MeI, dry 
THF, 70oC, 6 h. 
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22 was refluxed with thiourea in ethanol at 80oC for 4 days.35 The starting 
material was recovered unreacted. After failure of this attempt we planned 
another synthetic route (Scheme 14). 
 
                
     Scheme 14. Synthesis of 20a. (i) NaN3, water, 100oC, 24 hr; (ii) NEt3, MeI, dry THF, 80oC, 
6 h. 
 
The plan involved first refluxing isothiocyanate 27 with NaN3 in water at 
100oC for 24 h to yield 26 36 followed by methylation to obtain 20a.  The first 
reaction was successful and 26 was obtained in 83% yield. However, the 
attempted methylation of 26 with triethyl amine and methyl iodide in THF at 80 oC 
for 6 h37 yielded (methylthio)-1-phenyl-1H-tetrazole 28 instead of 1-methyl-4-
phenyl-1H- tetrazol-5(4H)-thione 20a owing to the greater nucleophilicity of 
sulfur. (Scheme 15).   
 
                                      
                    Scheme 15. Methylation of 1-methyl-4-phenyl-1H- tetrazol-5(4H)-thione, 20a. 
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 We tried one last approach for methylation of 26 that involved stirring 26 
with methyl benzoate in DMSO.38 After 4 days, starting material was found 
unreacted. 
 After trying all possible methods for synthesis of 1-methyl-4-phenyl-1H- 
tetrazol-5(4H)-thione 20a, we decided to follow our sole successful thionation 
with P2S5.  Care was taken to ensure the dry conditions for this reaction by using 
freshly distilled toluene. Thus, 1, 4-disubstitued tetrazolone analogs 25a-d were 
thionated by refluxing in dry toluene with P2S5 at 110 o C. 22 After work up, pure 
products were obtained by column chromatography. 25a was refluxed for 2 days 
that gave 1-methyl-4-phenyl-1H- tetrazol-5(4H)-thione 5a in 53% yield, 25b was 
refluxed for 20 h to obtain 1-methyl-4-(4-methoxyphenyl)-1H-tetrazol-5(4H)-
thione 20b in 75% yield, 25c was refluxed for 28 h to yield 1-methyl-4-(4-
chlorophenyl)-1H-tetrazol-5(4H)-thione 20c in 68% yield, and 25d was refluxed 
for 24 h to obtain 1-methyl-4-(4-nitrophenyl)-1H-tetrazol-5(4H)-thione 20d in 50% 
yield (Scheme 16).   
  
                                 
Scheme 16.   Thionation of 25a-d. P2S5, dry toluene, 110oC, (25a) 2 days, (25b) 20 h, (25c) 
28 h, (25d) 24 h 
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II. 2. Photochemical Studies 
 We used THF and MeCN for the photochemical studies of compounds 
20a-d. The solubility of our compounds is good in these two solvents. Also, these 
two solvents do not absorb significantly beyond 200 nm where our compounds 
exhibit significant absorbance. 20a-d were also soluble in acetone and dimethyl 
sulfoxide, however, these solvents were not used for our studies since they 
absorb significantly at 254 nm. 
 
II. 2. 1. Absorption Spectra of Tetrazolethione Analogs 
 The absorption spectra of 20a-d in THF and MeCN are shown in Figure 1 
(i)- (ii). Two absorption bands λ1 and λ2 were observed for all the compounds 
which underwent blue-shifts on going from less polar solvent THF to the more 
polar solvent MeCN. Comparing the effect of para substituents on the aromatic 
ring, it was observed that the presence of OMe group on aromatic ring in methyl-
4-(4-methoxyphenyl)-1H-tetrazol-5(4H)-thione 20b had negligible effect (a shift of 
1-3 nm) on the position of both bands with respect to 20a. The presence of Cl 
group did not have much effect on λ1; however, λ2 was red shifted by 
approximately 7 nm in both solvents. Significant effect on positions of λ1 and λ2 
was observed in case of NO2 substituent.  The first band was blue shifted (11-13 
nm) whereas the second band was significantly red shifted (40-44 nm) with 
respect to 20a in both solvents.  
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        Figure 1. Overlay of 1, 4- disubstitued tetrazolethiones spectra in (i) THF, (ii) 
Acetonitrile. 
 
Previous studies by Gosavi and Rao on substituted thioureas 39  suggest 
that λ1 is due to π → π * transition of the thione group of the tetrazolethione ring. 
The blue shift in λ1 on going from less polar THF to more polar MeCN and the 
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extinction coefficients for this band are consistent with Gosavi and Rao’s findings 
(Table 1). λ2 is due to an intramolecular negative charge transfer from the 
tetrazolethione ring nitrogen to the aromatic ring. This band is comparatively 
broad and sensitive to the substituents on the aromatic ring; this type of effect 
has been observed in donor- acceptor substituted aromatic compounds. 40-42  
 
                 THF                                              MeCN 
             λ1       log ε        λ2      log ε           λ1       log ε      λ2      log ε  
 20a     265      3.90      290     3.70  260  3.90    282     3.63 
 20b     267      3.95      287     3.72           261     3.90      281     3.81    
 20c     266      3.82      297      3.80          263     3.90      289     3.81 
 20d     251      4.20      336      3.80          250     4.30      328     3.90      
 
λ  in nm; ε in M-1 cm-1 
 
Table 1.  Absorption band positions and extinction coefficients 
 
The increase in charge transfer is observed as the substituent changes 
from electron donating to electron withdrawing ( OCH3 < Cl < NO2) on going from 
20b →20c → 20d. The considerable red shift in case of 20d is due to significant 
negative charge transfer to the NO2 substituent which is not possible in case of 
20b and 20c (Scheme 17). Further, a significant blue shift in λ2 is observed in 
case of 20d on going from less polar solvent THF to more polar solvent MeCN. 
This maybe due to the increased charge stabilization in more polar MeCN. 
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                  Scheme 17. Intramolecular charge transfer in 20d 
 
II. 2. 2. Photolysis of Tetrazolethiones 
We used 100 W medium-pressure quartz mercury lamp for photolysis of 
THF and MeCN solutions of1, 4- disubstituted tetrazolethione analogs 20a-d. 
The solutions were photolyzed at 254 nm. The change during photolysis of each 
solution was followed with UV and HPLC analyses. An aliquot was also taken out 
during irradiation of each solution for LCMS and GCMS analysis of the product 
mixture. 
 
II. 2. 2. 1. UV and HPLC Analyses 
UV and HPLC analyses were carried out to follow the photolysis 
experiments. The UV spectra were taken using UV- VIS spectrophotometer at 
Kansas State University.  The HPLC chromatograms were obtained using the 
Shimadzu HPLC instrument. The chromatograms were recorded at 254 nm.  
An overlay of UV spectra and HPLC chromatograms for irradiation of THF 
solution of 1-methyl-4-(4-nitrophenyl)-1H-tetrazol-5(4H)-thione 20d is shown in 
Figure 2. The overlay of UV spectra and the HPLC chromatograms for photolysis 
of 20a-c is shown in Appendix III and IV, Supporting Information. 
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(i) 
  
 
 
 
 
     
                                  
(ii)  
 
  Figure 2. Overlay of (i) UV spectra and (ii) HPLC chromatograms recorded during 
photolysis of 1-methyl-4-(4-nitrophenyl)-1H-tetrazol-5(4H)-thione(20d) in THF. 
 
It can be seen from the overlayed UV spectra and HPLC chromatograms 
that a mixture of products is formed during the photolysis of samples. Therefore, 
we do not observe a clear isobestic points in the overlayed UV spectra.  
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II. 2. 2. 2. Rate Constants 
 The overlayed UV spectra were used for determination of rate constants 
for photodecomposition of compounds 20a-d. The absorbance of the second 
band, λ2 observed in the UV spectra of each compound was followed for plotting 
ln (A/Ao) vs. irradiation time Figure 3 (i)- (ii).  
 
Figure 3 (i). Photochemical decomposition of tetrazolethiones. ln (A/Ao) vs. Irradiation time 
plots for THF solutions 
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Figure 3 (ii). Photochemical decomposition of tetrazolethiones. ln (A/Ao) vs. Irradiation 
time plots for MeCN solutions. 
 
The straight line in these plots indicates the first order kinetics for the 
photochemical decomposition reactions. The rate of decomposition was low for 
both THF and MeCN solutions of each compound; the rate in MeCN being lower 
than that in THF. We believe that λ2 might be responsible for the photochemical 
decomposition of tetrazoelthiones. This is also supported by the fact that the rate 
of photodecomposition of 20d was reduced to a great extent in more polar MeCN 
which may be explained by the greater stabilization of the intramolecular charge 
transfer (20d’ Scheme 17) in this solvent. 
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II. 2. 2. 3. Quantum Yields 
 We used Ferrioxalate Actinometry 43-45 to calculate the quantum yields for 
the disappearance of starting materials 20a-d during photolysis experiments. 
This experiment involves irradiation of mixtures of ferric sulfate and oxalic acid 
solutions. Upon irradiation ferric ions reduced to ferrous ions and carbon dioxide 
is produced. The net reaction equation is shown below: 
                                               2Fe
3+ + C2O102- 2Fe2+ + 2CO2                                             
  
The irradiated solutions are then mixed with 1, 10-pheanathroline solution 
to yield red colored solutions which are produced as a result of complexation of 
ferric ions with phenanthroline (Scheme 18).  The ferrous-phenanthroline 
complex absorbs strongly at 510 nm; thus the amount of ferric ions produced 
during the irradiation is determined by obtaining absorption spectra which is used 
to calculate quantum yields for photolysis of compounds 20a-d. The unreacted 
ferric ions complex weakly with phenanthroline and the little amount of complex 
thus produced is transparent at 510 nm.  
 
       
                           Scheme 18. Formation of Ferrous- Phenanthroline complex. 
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In our experiments 2.6 x 10-5 M s -1 of Fe2+ was produced and the radiant 
power of our medium pressure mercury lamp was found to be 12.26 W at 254 
nm.   
The quantum yields were found to be low for our experiments (Table 2) 
Compared to that in THF, quantum yields were found to be lower in more polar 
MeCN. As explained for lower rates of photochemical decompositions in MeCN, 
lower quantum yields may also be due to the greater stabilization of the 
intramolecular charge transfer in more polar MeCN. Further, radiationless decay 
or fluorescence may also be responsible for these results. 
 
         Ф (THF)           Ф (MeCN)      
          20a       0.015                 0.010 
          20b       0.030                 0.015 
          20c       0.012                 0.012 
  20d       0.020                 0.004 
 
         Table   2.   Quantum yields 
 
II. 2. 2. 4. LC/MS Analyses 
      The LCMS analyses of the irradiated THF and MeCN solutions were done 
at the University of Missouri-Columbia. A positive ion electronspray ionization 
mass spectroscopy (ESI) was performed on each photoproduct.  
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The ESI-MS of the samples revealed the presence of a urea in both THF 
and MeCN product mixtures for all compounds except for 20d which suggests 
that during photolysis a carbodiimide product 29a-c forms which is hydrolyzed to 
urea 30a-c by water present in the mobile phase used for LCMS analysis 
(Scheme 19) 
    
     
 Scheme 19. Photolysis of tetrazolethiones 20a-c. Hydrolysis of the photoproduct 
carbodiimide 29a-c to urea 30a-c. 
 
Only urea product was observed with LCMS analyses. Other peaks 
including the starting material could not be ionized by electrospray. However, the 
presence of remaining starting material is confirmed from HPLC chromatograms 
taken before and during irradiation of samples. Since we have difficulties in 
ionizing the samples with electrospray, we decided to analyze the reaction 
mixtures by GCMS analysis.  
 
II. 2. 2. 5. GC/MS Analyses 
 An EI-GCMS analysis of photolyzed THF and MeCN reaction mixtures 
was carried out at University of Kansas. A mixture of five photoproducts and the 
remaining starting material was observed for each sample except for 20d. The 
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five products were the diaziridine-3-thione, isothiocyanate, azide, carbodiimide 
and the hydrolyzed product of carbodiimide, the urea. In case of 20d, azide was 
not observed for both THF and MeCN samples. 
Irradiation of THF and MeCN solutions of 1-methyl-4-phenyl-1H-tetrazol-
5(4H)-thione 20a produced 1-methyl-2-phenyldiaziridine-3–thione 31a (m/z = 
164), 1-isothiocyanatobenzene 32a (m/z = 135), 1-azidobenzene 33a (m/z = 
119), N-(methylcarbonimidoyl)-benzeamine 29a and the hydrolyzed product of 
29a, 1-methyl-3-phenylurea 30a. Similarly, EI-GCMS analysis of 20b and 20c 
indicated the formation of five products. As in case of 20a, a peak for unreacted 
20b and 20c was observed in the product mixtures. Upon irradiation, the THF 
and MeCN solutions of 20b and 20c yielded diaziridine-3-thiones 31b and 31c 
(m/z = 194 and m/z=198 respectively), isothiocyanates 32b and 32c (m/z =  165 
and m/z = 169 respectively), azides 33b and 33c ( m/z = 149 and m/z = 153 
respectively), carbodiimides 29b and 29c ( m/z = 162 and m/z = 166 
respectively) and ureas 30b and 30c ( m/z = 180 and m/z = 184 respectively). 
(Scheme 20) 
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                      Scheme 20.  Photochemical decomposition products 
 
EI-GCMS analysis of irradiated THF and MeCN solutions of 20d indicated 
that it may undergo photodecomposition analogous to other tetrazolethiones. 
However, only four products were observed along with unreacted 20d for the 
MeCN reaction mixture. These products were 1-methyl-2-(4-nitrophenyl) 
diaziridine-3-thione 31d (m/z = 209), 1-isothiocyanato-4-nitrobenzene 32d (m/z = 
180), N-(methylcarbonimidoyl)-4-nitrobenzenamine 29d (m/z = 177) and 1-
methyl-3-(4-nitrophenyl) urea 30d (m/z = 195).  29d was not observed in the THF 
sample. Also, 1-azido-4-nitrobenzene 33d (m/z = 164) was not observed in both 
THF and MeCN samples. GCMS analysis suggested that the traces of products 
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were produced upon irradiation of 20d compared to 20a- c. These results were in 
agreement with the results found for photodecomposition of a monosubstituted 
tetrazolethione.46   Scheme 20 shows four different paths leading to 5 different 
products for photolysis of 20a-d. 
The trace amount of the photoproducts in case of 20d may be due to the 
photoreduction47 of nitro group to yield an amine under the experimental 
conditions. These formed amines may polymerize which would be difficult to 
identify by GCMS. 
 
II. 2. 2. 6. HPLC separation and NMR analysis 
 In order to obtain further spectroscopic evidence for the formation of these 
photoproducts, we decided to separate the photoproducts using HPLC and 
analyze the products via 1H-NMR and 13C-NMR spectroscopy.  
We first carried out large scale photolysis reaction for 1-methyl-4-phenyl-
1H- tetrazol-5(4H)-thione 20a. 100 mg of 20a was dissolved in 150 ml of THF. 
The solution was irradiated for 1 h with a medium pressure mercury lamp in a 
quartz photochemical reactor. A sample of unirradiated solution of 20a was 
analyzed by HPLC. After irradiation, another sample was analyzed by HPLC, The 
chromatogram of crude product mixture is shown in Figure 4  
  In the chromatogram of concentrated product mixture, the peak with 
retention time of 10.7 min corresponds to the unreacted starting material, 1-
methyl-4-phenyl-1H-tetrazol-5(4H)-thione 20a as confirmed from the 
chromatogram obtained for HPLC run of unirradiated sample.   
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               Figure 4. HPLC chromatogram of irradiated 1-methyl-4-phenyl-1H-tetrazol-5(4H)-thione 
20a.  
 
From the 1H-NMR analysis, it was found that the peak with retention time 
of 5.1 min (Figure 4) corresponds to 1-methyl-3-phenylurea 30a. This product 
was also found during LCMS and GCMS analyses. As explained earlier, this 
product is formed via hydrolysis of the photoproduct N-(methylcarbonimidoyl)-
benzeamine 29a during HPLC analysis (Schemes 19 and 20). Thus, 29a is not 
observed during LCMS or HPLC analyses but its hydrolyzed product 30a is 
observed instead. 
Similarly, we separated and analyzed products obtained during photolysis 
of methyl-4-(4-chlorophenyl)-1H-tetrazol-5(4H)-thione 20c. The solution was 
made by dissolving 100mg of 20c in 100 ml of MeCN and was irradiated in a 
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quartz photochemical reactor for 2 h and 5 min. The chromatogram for the crude 
irradiated solution is shown in Figure 5.  
 
Figure 5. HPLC chromatogram of irradiated methyl-4-(4-chlorophenyl)-1H-tetrazol-5(4H)-
thione 20c. 
 
The separated products were analyzed by 1H-NMR spectroscopy. Only 
two products along with the unreacted starting material were identified for 
photolyzed MeCN solution of 20c.  
As in case of 20a, the unreacted starting material was identified by 
comparison of the chromatogram of crude product with the chromatogram 
obtained for the unirradiated MeCN solution of 20c (Figure 5). The first 
photoproduct which was successfully identified had a retention time of 12.3 min 
in the crude product mixture chromatogram (Figure 5); this product was found to 
be 1-methyl-3-(4-chlorophenyl) urea 30c by 1H-NMR analysis. This product was 
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also found during LCMS and GCMS analyses of the photolyzed MeCN solution 
of 20c.  
The second product which was identified by both 1H-NMR and 13C-NMR 
spectroscopy had a retention time of 15 min, it was identified to be 6-chloro-1,3-
dihydro-1-methyl-2H-benzimidazole-2-thione 34c (m/z = 198). We earlier 
hypothesized on the basis of GC-MS/MS analysis that this product was 1-methyl-
2-(4-chlorophenyl) diaziridine-3-thione 31c (m/z = 198). This type of product was 
also found by Fausto for the photolysis of 1-methyl-1H-tetrazole-5(4H)-thione. 46 
However, our 1H-NMR and 13C-NMR spectra confirm that this product is not a 
diaziridine-3-thione but a benzimidazole-2-thione based compound.  In case of 1-
methyl-1H-tetrazole-5(4H)-thione, there is no phenyl group present on the 
tetrazolethione ring which will allow the benzimidazole-2-thione like product to 
form, therefore, in their case only diazridine-3-thione is produced.  Note that 
these researchers identified this product using low temperature matrix-isolation 
IR spectroscopy as this highly unstable compound may be difficult to isolate in 
solution.   In our GC- MS/MS spectrum, the fragmentation pattern of earlier 
hypothesized 1-methyl-2-(4-chlorophenyl)-diaziridine-3-thione 31c could very 
well fit the fragmentation pattern of now confirmed 6-chloro-1,3-dihydro-1-methyl-
2H-benzimidazole-2-thione 34c.   The two products would have essentially the 
same fragmentation pattern due to the formation of a 4- chloro-phenyl 
isothiocyanate type radical ion (Figure 6). 
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                                                                                   34c 
             Figure 6. Mass spectrum of 6-chloro-1,3-dihydro-1-methyl-2H-Benzimidazole-2-thione 
34c.  
  
 The peak at 9.8 min (Figure 6) was also separated by preparatory HPLC, 
however, a clean 1H-NMR was not obtained. Further, purification by HPLC is 
required to obtain any concrete data for analysis of this compound.  
 Similarly, a THF solution of 20c was also irradiated under similar 
conditions. Again the solution was made by dissolving 100mg of 20c in 100ml of 
THF. The solution was irradiated with medium pressure mercury lamp for 2 h 40 
min. The irradiation time was longer than in MeCN solution. A dense liquid was 
obtained when irradiated sample was concentrated under vacuum. The TLC 
analysis showed a slow moving huge UV active spot. We believe that this dense 
liquid is a mixture of polymers formed by polymerization of THF during 
photolysis; all formed photoproducts are strongly embedded in this polymer 
or 
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mixture which results in a single spot on the TLC plate. A column 
chromatography purification was also performed to remove the polymer mixture 
but this attempt was futile. As a result we could not carry out separation of the 
products using HPLC. 
 The work on separation and NMR analysis of the photoproducts obtained 
for photolysis of the remaining THF and/ or MeCN solutions of 20a-d is intended 
in future. 
 
II. 2. 2. 7. Multiphoton Excitation 
 Multiphoton experiments were carried out using Ti: sapphire laser at 
Kansas State University. As mentioned earlier, our goal was to develop masked 
enyne- carbodiimide prodrugs, the enynyl- 1H- tetrazole- 5 (4H)- thiones 8 
(Scheme 7) for photodynamic therapy of cancers. We wanted to study if the 
multiphoton excitation could be used to unmask the tetrazolethione scaffold in 
(give the number for the prodrug) to generate the active enyne- carbodiimide 
drug locally in cancer cells.  This technique involves the use of 650-1050 nm 
laser to excite a UV active molecule. When an ultra fast laser (100 fs) is focused 
on a reaction mixture section, the high photon densities of the laser lead to 
excitation of the molecule due to simultaneous absorption of two or more 
photons.  
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                                           Figure 7. Multiphoton Excitation. 48 
 
Thus, two or more photons of longer wavelength provide together the 
same energy as a single photon in UV region (Figure 11)48 This technique is very 
important for biological applications since a visible or near IR region photon is 
employed for the excitation of the molecules instead of a UV wavelength which is 
harmful to cells. 49, 50 The laser beam is focused at one point, therefore, there is 
no photodamage outside the focal plane.  
We first tried photolysis of 1-methyl-4-(4-nitrophenyl)-1H-tetrazol-5(4H)-
thione 20d in THF using a 870 nm beam. In UV spectrum of 20d in THF, the first 
absorption band λ1 is at 251 nm and the second absorption band λ2 is at 336 nm. 
Therefore, it was expected that 20d would absorb three 870 nm photons during 
this experiment.  
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As in case of photolysis with UV light, a 4.2 ml of THF solution was kept at 
a distance of 10 cm from the laser source. The change during the experiment 
was followed with UV-VIS spectroscopy. The starting material 20d was found 
unreacted even after 8 h of irradiation. The solution was again irradiated for 8h 
next day; this time the THF solution was placed as close as possible to the laser 
source. Again, no change was observed in the UV spectrum of 20d after 8h. 
Since, “efficient multiphoton excitation requires the short pulses and high 
repetitive frequencies of the mode- locked lasers”, it maybe that the Ti: sapphire 
laser used for our experiment is not strong enough to cause any reaction.50 In 
that case, a stronger NdYAG laser with a shorter pulse width and higher 
repetitive rates could be useful for our experiments. It is also likely that our 
compound has a small three photon absorption cross-section; therefore, our 
compound is not excited during the experiment.  
The fluorescence spectra of unirradiated 20a-d in THF and MeCN, and 
that of their irradiated solutions were taken (see supporting information). This 
was to see if our multiphoton excitation experiments could be followed with 
fluorescence spectroscopy in future. The spectra were taken in Dr. Higgins’ 
laboratory. However, the spectrometer recorded emission spectra starting at 330 
nm.  Near this region there was no significant difference between the 
fluorescence intensities of unirradiated and irradiated solutions of our 1, 4-
disustitued tetrazolethione analogs. Therefore even if multiphoton excitation 
experiments are successful, they cannot be followed with fluorescence 
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spectroscopy since the fluorescence spectrometer records the emission spectra 
starting at 330 nm.  
Considering all above described results, we conclude that there is a need 
for synthesis of new 1, 4-disubstiuted tetrazolethione analogs with UV absorption 
and fluorescence emission lying close to the visible region of light. This could be 
achieved by adding more electronically deactivating substituents on the phenyl 
ring subsituent of the tetrazolethione system. Also, instead of adding a methyl 
group on the tetrazolethione ring, some other substituents that could shift the UV 
absorption or the fluorescence emission closer to the visible region could be 
placed at the tetrazolethione ring. Thus, we could still use Ti- Sapphire laser for 
our experiments if our compounds have bigger two photon absorption cross-
section.  
 
III. CONCLUSIONS 
The photolysis of THF and MeCN solutions of 20a-d was performed using 
medium pressure mercury lamp. The rate of decomposition terazolethiones and 
the quantum yields of photoirradiation experiments depend upon the nature of 
substituents on the phenyl substituent. This effect is however not so pronounced.  
The LCMS and GCMS analyses of irradiated THF and MeCN solutions of 
20a-d suggest the formation of isothiocyanates, azides, carbodiimides, ureas and 
benzeimidazole-2-thione. The analysis of THF solution could not be carried out 
since a polymeric mixture was formed during irradiation.   
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The experiments for THF solution of 20a and MeCN solution of 20c need 
to be repeated at larger scale to confirm the presence of any other products 
detected during GCMS analyses for UV irradiated solutions of these solutions. 
The experiments need to be conducted for spectroscopic analysis of products 
formed for the remaining MeCN solution of 20a and THF solution of 20c and; for 
the photolysis of 20b and 20d in THF and MeCN.  
The multiphoton excitation experiment was not successful for the 
irradiation of 20d which decomposes at a very fast rate with UV light. This 
experiment needs to be repeated with more powerful NdYAG laser. New analogs 
with different aromatic substituents need to be synthesized to further bring the 
UV absorption and the fluorescence emission bands closer to the visible region 
of light.  
Our studies prove that it is possible to fine tune the photochemical 
properties of the tetrazolethione systems by modifying the substituents. The new 
analogs could be used for the development of a novel class of anticancer 
prodrugs for photodynamic therapy of cancers.   
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CHAPTER 1  
Photochemistry of 1,4-Disubstituted Tetrazolethiones 
 
EXPERIMENTAL SECTION 
I. 1.Synthesis  
5-Chloro-1-phenyl-1H-tetrazole (22)29: A mixture of sodium azide (3.0 g, 46.15 
mmol) and tetrabutylammonium bromide (0.650 g, 2.02 mmol) in water (8.7 mL) 
was added to a solution of phenyl-1,1-dichloroisocyanide (21) (5.0 g, 28.73 
mmol)  in toluene (42.4 ml). The mixture was stirred at room temperature and 
monitored by TLC until the starting material disappeared. After 2.5 h the aqueous 
layer was saturated with NaCl and the organic layer was extracted with toluene 
thrice and dried over Na2SO4. The organic layer was concentrated under reduced 
pressure.  The flask was then kept at -5oC until the crystals of 22 started to 
appear (approximately 2 - 5 minutes) which were recovered by filteration.  The 
supernatant was further concentrated, cooled to -5oC to recover more crystals.  
The latter process was repeated twice.  Compound 22 (3.8 g, 73% yield) was 
obtained as white crystalline material: Rf 0.3 (80:20 hexane:ethylacetate); 1H-
NMR (400 MHz, CDCl3): δ 7.58-7.65 (m, 5H); 13C NMR (400 MHz, CDCl3): δ 
124.70, 130.11, 131.11, 132.80, 145.73.  LRMS (ESI): m/z 198 (M + NH4 +), 181 
(M + H+), 153, 138, 118, 92, 77. 
 
1-Phenyl-1H-tetrazol-5(4H)-one (23a)30.  22 (3.7 g, 20.49 mmol) was added to a 
mixture of 2 M aqueous NaOH (55.7 mL) and ethanol (18.6 mL). The mixture 
 45 
was refluxed at 70 oC until the starting material disappeared (approximately 2 h).  
The reaction mixture was cooled in ice that resulted in the separation of a side 
product in the form of a colorless solid that was removed by filteration.  
Acidification of the filterate with concentrated HCl (pH = 3-5) afforded a thick 
white precipitate that was filtered, washed with water and air dried.  Compound 
23a (3.15 g, 95% yield) was obtained as a white solid: Rf 0.22 (40:60 
hexane:ethylacetate); 1H-NMR (400 MHz, DMSO): δ 7.42 (t, J = 7.51 Hz, 1H), 
7.56 (t, J = 7.60 Hz, 2H), 7.85 (d, J = 7.68 Hz, 2H); 13C NMR (400 MHz, DMSO): 
δ 119.48, 127.51, 129.39, 134.15, 150.17.  LRMS (ESI): m/z 180 (M + NH4 +), 
163 (M + H+), 135, 120, 107, 92, 80. 
 
1-(4-Methoxyphenyl)-1H-tetrazol-5(4H)-one (23b)31: Trimethylsilyl azide 
(TMSA) (0.773 g, 6.7 mmol) was added to 4-methoxyphenylisocyanate (24b) (0.5 
g, 3.35 mmol). The mixture was refluxed at 100oC for 24 h. The unreacted TMSA 
was removed under reduced pressure and the white residue was dried under 
vacuum.  Compound 23b (0.581 g, 90% yield) was obtained as a white solid: Rf 
0.45 (40:60 hexane:ethylacetate); 1H NMR (400 MHz,, DMSO): δ 3.81 (s, 3H), 
7.10 (d, J = 8.98 Hz, 2H), 7.71 (d, J = 9.17 Hz, 2H); 13C-NMR (400 MHz, DMSO): 
δ 55.45, 114.53, 121.97, 127.08, 150.46, 158.50.  LRMS (ESI): m/z 210 (M + 
NH4 +), 193 (M + H+), 165, 150, 137, 134, 122, 110. 
 
Similarly, compound 23c was prepared. 
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 1-(4-Chlorophenyl)-1H-tetrazol-5(4H)-one (23c)31: Compound 23c (0.605 g, 
95% yield) was obtained from 4-chlorophenylisocyanate (24c) (0.5 g, 3.26 mmol) 
as a white solid: Rf 0.55 (40:60 hexane:ethylacetate); 1H-NMR (400 MHz, 
DMSO): δ 7.89 (d, J = 8.72 Hz, 2H), 7.63 (d, J = 8.72 Hz, 2H); 13C-NMR (400 
MHz, DMSO): δ 120.98, 129.48, 131.67, 133.10, 150.13. LRMS (ESI): m/z 214 
(M + NH4 +), 197 (M + H+), 173, 169, 158, 141, 134. 
  
1-(4-Nitrophenyl)-1H-tetrazol-5(4H)-one (23d)30: Fuming HNO3 (3.5 ml) was 
added to 23a (1.0 g, 6.2 mmol). The mixture was refluxed at 100oC for 30 min 
during which formation of a yellow solid was observed.  The reaction mixture was 
poured over ice and cooled for 2 h to afford a thick yellow solid which was 
filtered, washed with plenty of water and air dried.  Compound 23d (0.749 g, 59% 
yield) was obtained as a yellow solid: Rf 0.18 (20:80 hexane:ethylacetate); IR 
(KBr) ν: 587, 688, 704, 720, 751, 861, 1032, 1055, 1112, 1337, 1352, 1375, 
1502, 1512, 1598, 1611, 1742, 3090, 3121, 3270cm-1; 1H NMR (200 MHz, 
DMSO): δ 8.43 (d, J = 9.15 Hz, 2H), 8.19 (d, J = 9.17 Hz, 2H); 13C NMR (400 
MHz, DMSO): δ 118.85, 125.15, 139.20, 145.40, 150.00.  LRMS (ESI): m/z 225 
(M + NH4 +), 208 (M + H+), 165, 121, 105, 91. 
 
1-Methyl-4-phenyl-1H-tetrazol-5(4H)-one (25a)32: A solution of dimethyl sulfate 
(0.83 g, 6.58 mmol) and methylene chloride (8.2 mL) was added to a mixture of 
23a (1 g, 6.17 mmol), tetrabutylammonium bromide (0.093 g, 0.29 mmol), 10% 
NaOH (12.4 mL) and methylene chloride (12.4 mL).  The reaction mixture was 
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stirred at room temperature for 3 h.  The organic layer was separated and 
washed with water thrice to remove tetrabutylammonium bromide and dried over 
Na2SO4. The dried organic layer was concentrated under reduced pressure and 
the residue dried under vacuum.  Compound 25a (0.91 g, 84% yield) was 
obtained as a crystalline colorless solid: Rf 0.81 (40:60 hexane:ethylacetate); 1H 
NMR (400 MHz, DMSO): δ 3.62 (s, 3H), 7.44 (t, J = 7.40 Hz, 1H), 7.58 (t, J = 
7.03 Hz, 2H), 7.85 (d, J = 8.27 Hz, 2H); 13C NMR (400 MHz, DMSO): δ 31.16, 
119.42, 127.73, 129.46, 134.23, 148.77.  HRMS (ESI), exact mass calculated for 
(M + Na+) C8H8N4ONa+ = 199.0596, found 199.0602.  
 
Similarly, compounds 25b – d were prepared.  
1-Methyl-4-(4-methoxyphenyl)-1H-tetrazol-5(4H)-one (25b)32: Compound 25b 
(0.396 g, 92% yield) was obtained from 23b (0.4 g, 2.08 mmol) as a white 
crystalline solid: Rf 0.51 (40:60 hexane:ethylacetate); mp 98 – 99 oC; IR (KBr) ν: 
511, 574, 729, 744, 824, 1028, 1048, 1155, 1252, 1357, 1424, 1519, 1618, 1721, 
2847, 2945, 2975, 3011, 3088 cm-1; 1H NMR (400 MHz, CDCl3): δ 3.70 (s, 3H), 
3.86 (s, 3H), 7.01 (d, J = 9.17 Hz, 2H), 7.80 (d, J = 9.17 Hz, 2H); 13C NMR (200 
MHz, CDCl3): δ 31.63, 55.75, 114.70, 121.61, 127.87, 149.62, 159.22.  HRMS 
(ESI), exact mass calculated for (M + Na+) C9H10N4O2Na+ = 229.0702, found 
229.0712.   
 
1-Methyl-4-(4-chlorophenyl)-1H-tetrazol-5(4H)-one (25c)32: Compound 25c 
(0.48 g, 90% yield) was obtained from 23c (0.5 g, 2.54 mmol) as a white solid: Rf 
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0.62 (40:60 hexane:ethylacetate); mp 91 – 93 oC; IR (KBr) ν: 512, 575, 708, 729, 
832, 839, 1014, 1092, 1138, 1387, 1423, 1496, 1597, 1732, 2854, 2928, 2958, 
3054, 3106 cm-1; 1H NMR (200 MHz, CDCl3) δ:  3.72 (s, 3H), 7.47 (d, J = 8.80 
Hz, 2H), 7.93 (d, J = 8.80 Hz, 2H); 13C NMR (400 MHz, CDCl3): δ 31.69, 120.49, 
129.78, 133.42, 133.55, 149.32.  HRMS (ESI), exact mass calculated for (M + 
Na+) C8H7ClN4ONa+ = 233.0206, found 233.0215.  
 
1-Methyl-4-(4-nitrophenyl)-1H-tetrazol-5(4H)-one (25d)32: Compound 25d 
(0.719 g, 96% yield) was obtained form 23d (0.71 g, 3.38 mmol) as a yellow-
brown solid: Rf 0.6 (20:80 Hexane:Ethylacetate); 1H NMR (200 MHz, DMSO): δ 
3.64 (s, 3H), 8.20 (d, J = 9.16 Hz, 2H), 8.45 (d, J = 9.15 Hz, 2H); 13C NMR (400 
MHz, DMSO): δ 31.32, 118.89, 125.29, 139.21, 145.61, 148.61.  HRMS (ESI): 
exact mass calculated for (M + H+) C8H8N5O3+ = 222.0627, found 222.0634. 
 
1-Methyl-4-phenyl-1H-tetrazole-5(4H)-thione (20a)22: P2S5 (12.0 g, 53.5 mmol) 
was added to a solution of 25a (4.0 g, 22.7 mmol) in toluene (82 mL). The 
mixture was refluxed for 2 days at 110oC until the starting material disappeared. 
The reaction mixture was filtered and the filtrate was dried over Na2SO4 and 
concentrated under reduced pressure. Purification by column chromatography 
(hexane:ethylacetate, 88:12) gave 20a  (2.3 g, 53% yield) as a yellow solid: Rf 
0.77 (40:60 hexane:ethylacetate); 1H-NMR (400 MHz, DMSO): δ 3.91 (s, 3H) 
7.68-7.55 (m, 3H), 7.87 (d, J = 7.14 Hz, 2H); 13C-NMR (400 MHz, DMSO): δ 
 49 
34.68, 124.30, 129.29, 129.76, 134.45, 163.23.  HRMS (ESI): exact mass 
calculated for (M + H+) C8H9N4S+ = 193.0548, found 193.0545. 
 
Similarly, Compounds 20b - d were synthesized. 
1-Methyl-4-(4-methoxyphenyl)-1H-tetrazole-5(4H)-thione (20b)22: Synthesis of 
20b was carried out from 25b (0.3 g, 1.46 mmol).  The refluxing time in P2S5 was 
20 h.  Purification by column chromatography (hexane:ethylacetate, 9:1) gave 
20b  (0.243 g, 75% yield) as a white crystalline solid: Rf 0.56 (60:40 
hexane:ethylacetate); mp 134 – 135 oC; IR (KBr) ν: 543, 561, 742, 825, 1028, 
1041, 1080, 1114, 1191, 1256, 1302, 1326, 1369, 1446, 1514, 1591, 1612, 2840, 
2926, 2965, 2998, 3076 cm-1; 1H NMR (200 MHz, CDCl3 ) δ: 7.82 (d, J = 9.16 Hz, 
2H), 7.05 (d, J = 9.16 Hz, 2H), 3.98 (s, 3H), 3.88 (s, 3H); 13C-NMR (200 MHz, 
CDCl3) δ: 35.17, 55.83, 114.62, 125.67, 127.85, 160.53, 163.93.  HRMS (ESI): 
exact mass calculated for (M + H+) C9H11N4OS+ = 223.0654, found 223.0645.  
  
1-Methyl-4-(4-chlorophenyl)-1H-tetrazole-5(4H)-thione (20c)22: Synthesis of 
20c was carried out from 25c (0.32 g, 1.52 mmol).  The refluxing time in P2S5 
was 28 h.    Purification by column chromatography (hexane:ethylacetate, 93:7) 
gave 20c  (0.235 g, 68% yield) as a white crystalline solid: Rf 0.62 (60:40 
hexane:ethylacetate); mp 137 – 139 oC; IR (KBr) ν: 544, 571, 718, 828, 1016, 
1080, 1095, 1201, 1368, 1389, 1494, 1590, 1721, 2855, 2924, 2953, 3077, 3097 
cm-1; 1H NMR (200 MHz, CDCl3) δ: 3.98 (s, 3H), 7.53 (d, J = 9.15 Hz, 2H), 7.99 
(d, J = 8.80 Hz, 2H); 13C-NMR (200 MHz, CDCl3) δ: 35.05, 124.71, 129.56, 
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133.36, 135.50, 163.57; HRMS (ESI): exact mass calculated for (M + H+) 
C8H8ClN4S+ = 227.0158, found 227.0161.  
 
1-Methyl-4-(4-nitrophenyl)-1H-tetrazole-5(4H)-thione (20d)22: Synthesis of 20d 
was carried out from 25d (0.561 g, 2.54 mmol). The refluxing time in P2S5 was 24 
h.  Purification by column chromatography (hexane:ethylacetate, 9:1) gave 20d  
(0.303 g, 50% yield) as a yellow crystalline solid: Rf 0.73 (40:60 
hexane:ethylacetate); mp 141 – 143 oC; IR (KBr) ν: 549, 568, 684, 702, 749, 854, 
1038, 1068, 1109, 1328, 1340, 1365, 1494, 1529, 1593, 1614, 2853, 2963, 3093, 
3120 cm-1; 1H NMR (200 MHz, DMSO): δ 3.92 (s, 3H), 8.33 (d, J = 8.42 Hz, 2H), 
8.49 (d, J = 8.42 Hz, 2H); 13C-NMR (200 MHz, DMSO): δ 34.78, 124.61, 124.83, 
139.22, 147.23, 163.23. HRMS (ESI): exact mass calculated for (M + H+) 
C8H8N5O2S+ = 238.0399, found 238.0387.  
 
I. 2. Photolysis of tetrazolethione analogs 
The solutions of 20a- d were made in THF and MeCN and were irradiated 
at 254 nm. The initial concentrations of the unirradiated THF and MeCN solutions 
was 0.45 and 0.40 mM for 20a, 0.28 and 0.22 mM for 20b, 0.49 and 0.37 mM for 
20c and; 0.17 and 0.13 mM for 20d respectively. The lamp was placed 10 cm 
away from the sample and was allowed to warm up for 5 min before the 
experiment was conducted. 4.2 ml of each solution was taken in a quartz cuvette 
and was irradiated in UV light. A UV spectrum was taken for each solution at 0, 
2, 3, 5, 10, 15, 20, 25, 30 min intervals during irradiation. At these intervals, an 
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aliquot of 10μl was also taken out which was analyzed using HPLC. An external 
calibration curve for each solution was constructed using HPLC and the amount 
of starting material left after each interval of irradiation was determined by using 
these curves.   
An aliquot was also taken out during irradiation of each solution for LCMS 
and GCMS analysis of the product mixture. The samples were collected after 
irradiation for 15 and 20 min for 20a, 10 and 15 min for 20b, 20 and 15 min for 
20c and; 20 and 15 min for 20d solutions made in THF and MeCN respectively. 
 
I. 3. Ferrioxalate Actinometry 
We prepared 100 ml of 0.0113 M ferric sulfate 7-hydrate, 25 ml of 0. 356 
M oxalic acid and  1, 10- phenanthroline solution obtained by dissolving 0.5g of 
phenanthroline in 1 ml glacial acetic acid and 24 ml water. 
 For this experiment, seven separate reaction mixtures were prepared by 
mixing 3.36 ml of ferric sulfate solution and 0.84ml of oxalic acid solution. These 
mixtures were irradiated in quartz cuvettes for 30, 60, 90, 120, 150 and 180 s.  
0.2 ml of each irradiated mixture was mixed with 0.1 ml 1, 10- phenanthroline 
and 2.7 ml water and an absorption spectrum was taken at 510 nm. The amount 
of Fe2+ produced was calculated using the absorption spectra obtained from 
ferrioxalate actinometry experiment. 
We used the data collected from HPLC analysis and ferrioxalate 
actinometry to calculate quantum yields for our photolysis experiments. As 
mentioned before (Section: II. 2. 3.), we used HPLC to determine the change in 
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amount of starting materials during the irradiation of our THF and MeCN 
solutions of 20a-d. This information was used to calculate the rate of 
disappearance of starting materials over time.  Using this information along with 
the amount of Fe2+ produced from ferrioxalate actinometry, we calculated 
quantum yields for the disappearance of each starting material in THF and 
MeCN. 
 
I. 4. HPLC separation  
I. 4. 1. Photolysis of THF solution of 20a 
100 mg of compound 20a was dissolved in 150 ml of THF. The solution 
was irradiated for 1 h with a medium pressure mercury lamp in a quartz 
photochemical reactor. The irradiated solution was collected and concentrated 
under pressure. The contents were dissolved in 3ml of 50: 50 MeCN: H2O 
mixture and a 10μl of this sample was injected for HPLC analysis. The mobile 
phase used for HPLC run was initially 100% water and concentration of MeCN 
was increased linearly from 0% to 100% over 20 min. The total flow rate was 
1ml/ min. A sample of unirradiated solution of 20a was also analyzed by HPLC.  
TLC analysis of the crude irradiated sample was done to gather 
information about the components present in appreciable quantity in the product 
mixture. Thus, all components corresponding to the UV active spots were 
separated by column chromatography. The separated fractions were 
concentrated to dryness under pressure and were dissolved in 3ml of 50: 50 
MeCN: H2O mixtures for further analysis by HPLC to check for various 
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photoproducts. The photoproducts in each fraction were separated by 
preparatory HPLC. Since there were no products in the beginning of the HPLC 
run for the crude product mixture (as seen from chromatogram of crude product 
mixture) we decided to start the preparatory HPLC runs with an initial mobile 
phase of 30% water -70% MeCN mixture. The concentration of MeCN was 
increased linearly from 30% to 100% over 15 min. The total flow rate was 4.73 
ml/ min. The separated product solutions were concentrated under pressure and 
dried under vacuum. The dried products were analyzed by 1H-NMR 
spectroscopy. 13C-NMR was also taken whenever required. We used d6-acetone 
or d-chloroform for preparing NMR solutions. 
 
I. 4. 2. Photolysis of MeCN solution of 20c  
Similarly, 100 mg of 20c was dissolved and irradiated for 2h and 5 min. 
Chromatographic and HPLC separation was carried out as mentioned above for 
20a. The separated products were analyzed by 1H-NMR. 13C-NMR was taken 
whenever required. 
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CHAPTER 2 
Bio- evaluation of cytotoxicity of 1-methyl-4-(4-chlorophenyl)-1H-tetrazol-
5(4H)-thione against MCF-7 cell line 
 
I. INTRODUCTION 
Tetrazole based compounds have wide variety of applications. There are 
many known compounds which are potent pharmaceutical agents and many 
others with other useful applications. Some of the pharmaceutically important 
compounds are shown in Scheme 1 .The compound 1 is patented for treatment 
of pain, neurodegenerative diseases, addiction disorders, sexual dysfunction1; 
the compound 2 is antihypertensive drug2; the compound 3 is a potent HIV 
protease inhibitor3 and; the compound 4 is anticarcinogenic4.  
      
 
Scheme 1. Tetrazole based compounds 
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I. 1. Our Goal 
 Our goal was to test the tetrazolethione analogs 20a-d (Scheme 2) 
synthesized in our laboratory (Chapter-1) for their cytotoxicity against MCF-7 cell 
line.   
 
                                  
Scheme 2. Tetrazolethione analogs 
  
II RESULTS AND DISCUSSION 
Initially, we tested only 1-methyl-4-(4-chlorophenyl)-1H-tetrazol-5(4H)-
thione 20c for it’s cytotoxicity against MCF-7 cancer cell line via MTT (3-(4,5-
dimethylthiazoyl-2-yl)2,5-diphenyltetrazolium-bromide) assay. 50,000 cells per 
well were seeded out in three 96-well plates carrying 100μl of 10% MEM per well. 
The plates were incubated at 37oC in presence of 5% CO2.         
A time dependent study was performed for cytotoxicity of 20c on MCF-7 
cells. The cells in all three plates were dosed with 1 nm, 10 nm, 100nm, 500nm 
and 1μm of 20c solution made in DMSO after 24 hr ( second day) of incubation. 
Some wells were not dosed with compound solution for maintaining control. MTT 
assay was performed on one of the dosed plates on the third day. The cells in 
other two plates were again dosed with same concentration solutions. After 48 hr 
of dosing, i.e., on the fourth day, one of the remaining plates was used for MTT 
assay. This was to study the effect of different concentrations of 20c after 48 hr 
of treatment. The remaining third plate was again dosed with the same 
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concentration solutions and incubated for another 24 hr. On the fifth day the MTT 
assay was performed to study the effect of our compound solutions after 72 hr of 
treatment.  
The data collected for each MTT assay was used to plot % cell viability 
against the 20c concentration. ±SE was also plotted for each data point. The 
plots thus obtained are shown in Figure 1. A comparative plot of % cell viability 
vs. treatment for three assays was also made (Figure 2).   
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Figure 1. % cell viability of MCF-7 cells after 24 hr, 48hr and 72hr of treatment with 
20c solutions. The bar on each data point represents ±SE for that data. 
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Figure 2. Comparative plot for 24 hr, 48 hr and 72 hr of treatment. 
 
 The % cell viability was found to be low for 48 hr treatment of MCF-7 cells 
with all concentrations of 1-methyl-4-(4-chlorophenyl)-1H-tetrazol-5(4H)-thione 
20c solutions. Further, 10nM was found to be the most effective concentration of 
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20c for inhibition of MCF-7 cells proliferation. The % cell viability for 48 hr 
treatment of this concentration solution was found to be 30% with 2% ±SE. 
 Three multiples of 48 hr treatment assays were also performed to confirm 
the above results. However, this time cells were dosed with 10nM, 100nM, 
200nM and 500nM of 20c solutions. The results were found to be different from 
the experiment; %cell viability was found to be 55% with a 5% ±SE for average 
obtained from three assays. 
 
III. CONCLUSIONS 
 The time dependent study for treatment of 20c solutions suggests the 48 
hr treatment to be most effective for inhibition of MCF-7 cells proliferation. Among 
all concentrations of 20c solutions, 10 nM is the most cytotoxic concentration for 
48 hr treatment of MCF-7 cell line.  
 The above experiments need to be repeated before investigating the 
cytoxicity of 20c against MCF-7 cells. Other tetrazolethione analogs 20a, b, d 
need to be tested for their cytoxicity against MCF-7 cell line. MCF-7 cells are 
known to express both α2B and α2C adrenoceptors and tetrazolone based 
compounds are known to be effective α2C antagonists. Studies to investigate the 
cytoxicity of 20c and all other synthesized tetrazolethione analogs 20a, b, d 
against MCF-7 and other cell lines with α2B and/ or α2C adrenoceptors would 
prove to be beneficial for the development of novel α2B and/ or α2C antagonist 
based drugs. 
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CHAPTER 2 
Bio- evaluation of cytotoxicity of 1-methyl-4-(4-chlorophenyl)-1H-tetrazol-
5(4H)-thione against MCF-7 cell line 
 
EXPERIMENTAL SECTION 
I. 1. Cell Culture 
Cells were cultured in 10 % Minimum Essential Eagle’s Medium (MEM). 
This media was prepared by mixing 9.53 g MEM, 1. 5g NaHCO3, 10 ml of 100 
mM sodium pyruvate, 10 ml non-essential amino acids solution, 100ml fetal 
bovine serum, 10 ml antibiotic- antimycotic and 1 tube (0.01g/L) of insulin in 1L of 
water at room temperature.  
 
I. 2. Drug Treatment 
50,000 MCF-7 cells were seeded out in a 96 well plate and were 
incubated in 100 μl of 10 % MEM at 370C in presence of 5% CO2 for 24 h.  
 
I. 2. 1. Time dependent study  
Old media was removed and 100 μl of new media was added to MCF-7 
cells in three 96 well plates after 24 h of incubation. The cells were dosed with 1 
μl of 1 nM, 10 nM, 100nM, 500nM and 1μM 20c solutions made in DMSO after 
24 hr ( second day) of incubation. Some wells were not dosed with compound 
solution for maintaining control. On the third day, an MTT assay was performed 
on one of the dosed plates and the cells in other two plates were treated with 20c 
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solutions as described. After 48 h of treatment, i.e., on the fourth day, one of the 
remaining plates was used for MTT assay. This was to study the effect of 
different concentrations of 20c after 48 h of treatment. The remaining third plate 
was again dosed with the same concentration solutions and incubated for 
another 24 h. On the fifth day the MTT assay was performed to study the effect 
of 20c after 72 hr of treatment.  
 
I. 2. 3.  48 h Treatments 
The incubated cells were treated with 10nM, 100nM, 200nM and 500nM of 
20c solutions for 48 h as described earlier. MTT assays were performed on three 
multiples of 48 h treatment assays. 
 
I. 3.1  MTT cell proliferation assay 
MTT (3-(4,5-dimethylthiazoyl-2-yl)2,5-diphenyltetrazolium-bromide) was 
used to determine the % cell viability after treatments with solutions of 20c. The 
living cells metabolize MTT to formazan a purple colored compound which 
indicates the % cells surviving after treatment with a drug. After desired hours of 
treatment with 20c solutions, old media was removed and replaced with 100 μl of 
new media. A 10 μl of MTT (5mg/ml, in PBS) was added to each well and cells 
were incubated at 370C in presence of 5% CO2. After 2 h of incubation, formazan 
crystals were solubilized in each well by mixing with 100 μl solubilization solution 
(isopropanol in 0.04 N HCl). Absorbance was recorded using a plate reader. Two 
wavelength channels were used; 570 nm for recording the absorbance of each 
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well and 650 nm for recording the background absorbance. The net solution 
absorbance was obtained by subtracting the background absorbances from the 
absorbance of wells. % Cell viability was calculated according to the equation 1. 
 
% cell viability= (absorbance of treated cells/ absorbance of control) * 100      (1) 
 
% cell viability versus treatment plot for the average data of three multiples 
of 48 treatment assays was made. 
 
I. 3. 2 % Cell Viability versus Treatment plot for 48 h Treatments  
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               The % Cell Viability for 10 nM treatment was found to be 55% with 5% 
of ±SE.  
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PART TWO  
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CHAPTER 3 
Synthesis of 2-(2-(phenylimino)vinyl)benzonitrile 
 
I. INTRODUCTION 
I. 1. Enyne- Allenes and Enyne- heteroallenes 
 In Chapter-1 we discussed that potent naturally occurring anticancer 
antibiotics, enediynes undergo bergman cyclization upon heating to generate a 
biradical which cleaves DNA by abstracting the hydrogen atom from it’s sugar-
phosphate back bone.1, 2  These compounds though very potent antitumor agents 
are non-specific in their action and are known to exhibit high cytotoxicity towards 
normal cells.3-6 Due to this limitation, the DNA cleaving properties of these 
naturally occurring compounds have been utilized for designing new anticancer 
drugs with fewer or no side effects.  
One class of drugs that is inspired by enediynes is enyne-allene. Enyne- 
allenes undergo thermally and photochemically triggered C2- C7 or Myers–Saito 
and the C2-C6 or Schmittel cyclizations to generate α, 3- dehydrotoluene and 
fulvene-like biradicals respectively.7-11 The Schmittel pathway is favored when a 
bulky group (R=  Ph or t- Bu ) is present at the alkyne end of the enyne- 
allenes.12 The generated  biradicals mimic enediynes in their mode of action by 
abstracting hydrogen from the sugar phosphate back bone of the DNA and 
causing it’s cleavage13, 14 (Scheme 1). These biradicals are also known to 
abstract hydrogen atoms from hydrogen donors like 1, 4- cyclohexadiene 
(CHD).8, 12 
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                       Scheme 1. Myers- Saito and Schmittel cyclization in enyne- allenes. 
 
Similarly, hetero-allene based compounds have been synthesized. The 
replacements of one or more carbons in the allene moiety of the enyne-allenes 
gave rise to enyne ketenimines and enyne carbodiimides respectively (Scheme 
2)                      
                                                  
                                        Scheme 2. Enyne Ketenimine and Enyne Carbodiimide 
 
Enyne- ketenimines mimic enyne allenes by undergoing Myers- Saito and 
Schmittel cyclization to generate α, 3- dehydrotoluene 2 and azafulvene- like 
biradicals 3 respectively. The Schmittel pathway is favored when a bulky group 
(R = T-Bu, SiMe3, Ph) is present at the alkyne terminus.15- 17    
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Scheme 3. Schmittel (C2- C6) cyclization of ketenimine 2 followed by formal [4+2] 
cycloaddition.15 
 
Thermolysis studies have shown that in the presence of an aryl group at 
the ketenimine terminus, azafulvene- like biradical 2 undergoes formal [4+2] 
cycloaddition resulting in formation of a benzocarbazole product 5 (Scheme 3). 
However, Myers- Saito pathway is still favored if alkyne terminus is substituted 
with a small group (R= H) (Scheme 4).15, 16This is proved by detection of a 
quinoline product 9 formed as result of hydrogen abstraction from a hydrogen 
donor 1, 4- cyclohexadiene (1, 4- CHD). 
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Scheme 4. Myer- Saito cyclization favored by presence of a small group at the alkyne 
terminus. 15 
 
 Photochemical cyclization of enyne ketenimines with allenic aryl 
substituents has not been explored much. Only two compounds with bulky 
groups at the alkyne terminus are known to undergo formal [4+2] cycloadditions 
via azabenfulvene biradicals (Scheme 5).17        
              
                     
Scheme 5. Photochemical cyclization of enyne- ketenimines (9a, 10a) with bulky groups at 
the alkyne terminus.17 
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Upon photolysis, 9a and 10a are known to form the corresponding 
benzcarbazole products 9b and 10b. Some polymeric products were also 
detected along with benzocarbazoles.  Theoretical studies have revealed that the 
Myers- Saito cyclization may be responsible for the formation of the polymeric 
products.17, 18 
Similarly, carbodimides undergo thermally triggered Myers- Saito and 
Schmittel cyclization to generate α, 3- dehydropyridine and diazafulvene- like 
biradicals respectively. Again , the Schmittel pathway is favored when a bulky 
group (R = T-Bu, SiMe3, Ph) is present at the alkyne terminus. 19, 20 Just as in 
case of ketenimines, diazafulvene- like biradical 12 undergoes formal [4+2] 
cycloaddition resulting in formation of an indoloquinoline product 14 in the 
presence of an aryl group at the carbodiimide terminus 19, 20 (Scheme 6).  
 
Scheme 6. Schmittel (C2- C6) cyclization of carbodiimide 11a-b followed by formal [4+2] 
cycloaddition.20  
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Under photochemical trigger, carbodiimides are known to undergo 
Schmittel cyclization independent of size of the substituents at the alkyne 
terminus17 (Scheme 7). The Myers- Saito cyclization for photochemical reactions 
of carbodiimdes is unknown.   
                 
                            Scheme 7. Photochemical cyclization of enyne-carbodiimides.17 
 
Apart form Enyne- ketenimines and enyne – carbodiimides, other hetero 
analogs of enyne- allenes have been synthesized and their thermal and or 
photochemical cyclizations have been studied. A C-alkynyl- N-allenyl imine 15 
was synthesized and it’s thermal and photochemical cyclization was studied. 15 
undergoes facile Myers- Saito cyclization thermally and photochemically to 
generate an α, 5-didehydro-3-picoline biradical. The formation of this biradical 
was confirmed by formation of a product 17 via hydrogen abstraction from 1, 4- 
CHD (1, 4- cyclohexadiene) (Scheme 8).21 It is believed that Schmittel cyclization 
results in formation of complex unidentified products.             
                  
Scheme 8. Myers- Saito cyclization of C- alkynyl- N- allenyl imine 15 followed by H-     
abstraction from 1, 4- CHD. 21 
 70 
 
             
Scheme 9. Myers- Saito cyclization of benzannulated enyne isonitrile 17a-b followed by 
[4+1] formal cycloaddition.22 
 
Thermal cyclizations of benzannulated enyne- isonitrile analogs 19 have 
also been studied. These analogs undergo Myers- Saito cyclization to generate a 
biradical 20 or a zwitterion 21.  A subsequent intramolecular radical- radical 
coupling of 20 or an intramolecular electrophilic substitution of 21 followed by 1, 
3- H shift affords a 11H-indeno [1, 2b] quinoline product 23 (Scheme 9).22 Both 
20a or 21a maybe involved in formal [4+1] cycloaddition reaction of 17a whereas 
only biradical 20b is involved in formal [4+1] cycloaddition of 17b.  
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In 1996 Wang tried the thermal cyclization of another type of aza analogs 
of enyne- allenes; these analogs had a nitrile group serving as an alkyne 
functionality.16, 23 Compound 24a and 24a were expected to undergo the Myer- 
Saito cyclization to produce the corresponding substituted pyridine products 25b 
and 25b in the presence of hydrogen donor 1, 4- cyclohexadiene. However, the 
experiments were unsuccessful and resulted in the formation of unidentified 
mixture of products (Scheme 10). 16, 23 
                 
                       
           Scheme 10. Photochemical cyclization of nitrile substituted allenes 24a-b.2, 5   
 
I. 2. Our Goal 
The goal of our laboratory is to synthesize a series of mono, di and tri-
azaenyne-allenes to study their Myers- Saito and Schmittel cyclizations. If our 
studies are successful, these cyclizations could be employed for synthesis of 
heteroaromatic rings found in many compounds of biological importance. As a 
step towards our studies, our goal was to synthesize a nitrile substituted 
keteneimine, 2-(2-(phenylimino)vinyl)benzonitrile 25 and to study its thermal and 
photochemical cyclizations. As observed in case of enyne- ketenimines this 
ketenimine is expected to undergo formal [4+2] cycloaddition via Schmittel 
cyclization pathway. This experiment if successful would then yield the 
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anticipated product 11H-indeno [1, 2b] quinoxaline 28 via a novel synthetic route 
(Scheme 11).  
 
                
Scheme 11. Cyclization of 2-(2-(phenylimino)vinyl)benzonitrile (25) to the anticipated 
product 11H-indeno [1, 2b] quinoxaline (28).  
 
Quinoxaline based compounds are known to have various applications. 
Compound 29 24 in Scheme 12 is known to have antitumor properties and 
compound 30 25 is patented for its use for making organic light- emitting devices.  
Recently, synthesis of a pyrrole substituted quinoxaline compound was reported. 
The pyrrole substituted compounds are known to be important components of 
anti-inflammatory and antitumor agents, immunosuppressants.26-28 If our 
experiments are successful, this synthesis pathway could be employed for 
synthesis of quinoxaline based compounds of diverse applications. 
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                                Scheme 12. Quinoxaline based compounds.24, 25 
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II RESULTS AND DISCUSSION 
II. 1. Synthetic method 
 The synthetic plan was to first synthesize 2-(2-cyanophenyl) acetic acid 32 
from 2- (bromomethyl) benzonitrile 31 29 and then to convert it into a ketene 33.30 
The desired product, 2-(2-(phenylimino)vinyl)benzonitrile 25 could then be 
synthesized by stirring 33 with a phosphorane 34 in CH2Cl2 (Scheme 13).31    
                  
Scheme 13. Plan for synthesis of 2-(2-(phenylimino)vinyl)benzonitrile, 25. (i) [(Ph3P)2PdCl2], 
CHCl3/ 50% KOH, r.t., 24 h; (ii)  SOCl2, pyridine, toluene, 1150C, 30 min; (iii) dry CH2Cl2, r.t., 
30 min. 
 
2-(2-cyanophenyl) acetic acid 32 was synthesized by stirring under N2 a 
mixture of 2- (bromomethyl) benzonitrile 31 and bis(triphenylphosphine)palladium 
(II) chloride in the presence of CHCl3/ 50% KOH mixture. The reaction mixture 
was stirred at room temperature for 24 h and yielded 62% of 32. 29  
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Scheme 14. Synthesis of 21. (i) [(Ph3P)2PdCl2], CHCl3/ 50% KOH, r.t., 24 h; (ii)  SOCl2, 
pyridine, toluene, 1150C, 30 min. 
 
2-(2-cyanophenyl) acetic acid 32 was refluxed at 1150C in the presence of 
dry toluene/ pyridine and thionyl chloride to obtain ketene 33. Starting material 32 
disappeared in 30 min; however, the desired product 33 was not obtained 
(Scheme 14).   
 
After this unsuccessful attempt to synthesize 33, we decided to synthesize 
2-(2-(phenylimino)vinyl)benzonitrile 25 via another route (Scheme 15). The plan 
was to first convert 2-(2-cyanophenyl) acetic acid 32 into an acid chloride 3532 
and then synthesize the keteneimine 25 from it.  
 
       
 
Scheme 15. Synthesis of 2-(2-(phenylimino)vinyl)benzonitrile 25. (i) neat SOCl2, 800C, 30 
min; (ii) n-BuLi, THF, -700C for 90 min → r.t. for 24 h 
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32 was refluxed under N2 in neat thionyl chloride  for 30 min at 800C. The 
reaction mixture was analyzed by 1H-NMR before work up and it indicated 
formation of the desired acid chloride 35. The unreacted thionyl chloride was 
removed under reduced pressure on rotary evaporator. However, during removal 
of thionyl chloride our product reacted with moisture from air and decomposed 
back to the starting acid 32. The reaction was repeated and this time unreacted 
thionyl chloride was removed over vacuum line. The product stayed unreacted 
initially but started to decompose back to the starting material 32 over time. 
Repeated attempts to synthesize 2-(2-(phenylimino)vinyl)benzonitrile 25 were 
unsuccessful. The desired ketene 33 and acid chloride 35 were very unstable 
due to the presence of ortho nitrile substituent on the phenyl ring. 35 if formed 
decomposed back to yield the starting acid 32 by reacting with little moisture 
during removal of unreacted thionyl chloride. 
 
III. CONCLUSIONS 
 The desired keteneimine, 2-(2-(phenylimino)vinyl)benzonitrile 25 could not 
be synthesized due to instability of the intermediate compound acid chloride  35 
or ketene 33. As result, the desired studies towards thermal and photochemical 
cyclization of 25 and thus development of a novel route for synthesis of 11H-
indeno [1, 2b] quinoxaline 28 could not be carried out. 
 Studies towards synthesis of other azaenyne-allene analogs is going on in 
our laboratory. If synthesis is successful then thermal and photochemical 
cyclizations of these compounds could lead to development of new routes for 
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synthesis of heteroaromatic rings found in many compounds of biological 
importance. 
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CHAPTER 3 
Synthesis of 2-(2-(phenylimino)vinyl)benzonitrile 
 
EXPERIMENTAL SECTION 
I. Synthesis 
2-(2-Cyanophenyl) acetic acid (20)29: 50% KOH (13.08 ml) was added to 
CHCl3 (2.5 ml) and the resulting mixture was degassed. 2-(2-cyanophenyl) acetic 
acid 20 (2 g, 10.20 mmol) and bis(triphenylphosphine)palladium (II) chloride (0 
.074 g, 0.105 mmol) were added to the degassed reaction mixture. The reaction 
mixture was stirred under N2 at room temperature for 24 h. water (10 ml) and 
ethylacetate (7 ml) was added to the reaction mixture. The aqueous layer was 
separated, acidified with 20% HCl and extracted with ethylacetate thrice. The 
collected solution was dried over Na2SO4, concentrated under reduced 
pressure. Purification by column chromatography (hexane:ethylacetate, 60:40) 
gave 13  (1.015 g, 62% yield) as a light brown solid: Rf 0.28 (40:60 
hexane:ethylacetate); 1H-NMR (200 MHz, CD3COCD3): δ 3.95 (s, 2H), δ 7.47-
7.82 (m, 4H); 13C NMR (200MHz, CD3COCD3): δ 39.73, 114.46, 118.28, 128.73, 
132.05, 133.54, 133.85,  139. 60, 171.25.   
 
II. Unsucessful Synthesis 
2-Cyanophenyl-2-ketene (33)30: 2-(2-cyanophenyl) acetic acid 32 (0.050g, 
0.3103 mmol) was added to a mixture of thionyl chloride (0.13 ml), toluene (2 ml) 
and pyridine (0.030 ml). The reaction mixture was refluxed under N2 at 1150C for 
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30 min. Activated charcoal was added to the reaction mixture and the reaction 
mixture was filtered. The collected solution was dried over Na2SO4, 
concentrated under reduced pressure to yield a sticky solid. Acetonitrile (2 ml) 
was added to the sticky solid and the resulting solution was left for 
recrystallization overnight. TLC analysis revealed presence of a mixture of 
products. The non-polar products were extracted with hexane, concentrated 
under reduced pressure and dried over vacuum.  The non-polar component was 
analyzed by 1H-NMR and the remaining polar solution was analyzed by IR 
spectroscopy. 1H-NMR (200 MHz, CDCl3): Nothing about the identity of 
compound could be deduced from the nmr; IR (NaBr) ν: No band for ketene 
functionality observed.  
 
2-Cyanophenyl-2-acetic acid chloride (35)32: 2-(2-cyanophenyl) acetic acid 32 
(0.050g, 0.3103 mmol) was added to neat thionyl chloride (3 ml). the reaction 
mixture was refluxed under N2 for 30 min at 800C. The reaction mixture was 
analyzed by 1H-NMR before work up and it indicated formation of the desired 
acid chloride 35. Excess of thionyl chloride was removed under reduced 
pressure. 1H-NMR (200 MHz, CD3COCD3): Only the starting material 32 was 
found present, acid chloride 35 had hydrolyzed back to 32.  
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APPENDIX I 
 
1H-NMR AND 13C-NMR SPECTRA 
(Chapter-1) 
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APPENDIX II 
 
IR SPECTRA 
 
(Chapter -1) 
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APPENDIX III 
 
MASS SPECTRA 
 
(Chapter -1) 
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APPENDIX IV 
 
OVERLAYED UV SPECTRA OF PHOTOLYSIS EXPERIMENTS 
(Chapter -1) 
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I. Photolysis of 20a- c in THF 
 
 
     
 
(i) Photolysis of 20a. 
 
 
 
          
 
 
 
 
 
 
 
 
 
 
  
 
 
     (ii) Photolysis of 20b 
 
               
 
 
 
 
 
 
 
 
 
 
 
 
  
 
     (iii) Photolysis of 20c 
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II. Photolysis of 20a- d in MeCN 
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(i) Photolysis of 20a. 
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(ii) Photolysis of 20b. 
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(iii) Photolysis of 20c. 
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(iv) Photolysis of 20d. 
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APPENDIX V 
 
OVERLAYED HPLC CHROMATOGRAMS OF PHOTOLYSIS EXPERIMENTS 
(Chapter -1) 
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I. Photolysis of 20a- c in THF 
 
 
(i) Photolysis of 20a. 
 
 
(ii) Photolysis of 20b. 
 
 
Starting Material 
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(iii) Photolysis of 20c. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Starting Material 
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II. Photolysis of 20a- d in MeCN 
 
 
(i) Photolysis of 20a. 
 
 
(ii) Photolysis of 20b. 
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(iii) Photolysis of 20c. 
 
 
(iv) Photolysis of 20d. 
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APPENDIX VI 
 
LCMS SPECTRA OF PHOTOLYSIS PRODUCTS 
 
(Chapter -1) 
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APPENDIX VII 
 
GCMS SPECTRA OF PHOTOLYSIS PRODUCTS 
 
(Chapter -1) 
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APPENDIX VIII 
 
NMR SPECTRA OF PHOTOLYSIS PRODUCTS 
 
(Chapter -1) 
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APPENDIX IX 
 
HRMS SPECTRUM:6-CHLORO-1,3-DIHYDRO-1-METHYL-2H-
BENZIMIDAZOLE-2-THIONE 34c 
 
(Chapter -1) 
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APPENDIX X 
 
OVERLAYED FLUORESCENCE SPECTRA FOR PHOTOLYSIS 
EXPERIMENTS 
(Chapter -1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Photolysis of MeCN solutions of 20a-d 
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Fluorescence spectrum of 5a (260nm)
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(i) Fluorescence collected before and after 20 min of irradiation of 20a. Excitation 
wavelength: 260 nm   
 
            
Fluorescence spectrum of 5a (290nm)
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(ii) Fluorescence collected before and after 20 min of irradiation of 20a. Excitation 
wavelength: 290 nm  
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Fluorescence spectrum of 5b (260 nm)
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(iii) Fluorescence collected before and after 15 min of irradiation of 20b. Excitation 
wavelength: 260 nm  
    
Fluorescence spectrum of 5b (290nm)
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(iv) Fluorescence collected before and after 15 min of irradiation of 20b. Excitation 
wavelength: 290 nm  
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Fluorescence spectrum of 5c (260nm)
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(v) Fluorescence collected before and after 15 min of irradiation of 20c. Excitation 
wavelength: 260 nm  
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(vi) Fluorescence collected before and after 15 min of irradiation of 20c. Excitation 
wavelength: 290 nm  
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Fluorescence spectrum of 5d (260 nm)
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     (vii)  Fluorescence collected before and after 15 min of irradiation of 20d. Excitation     
      wavelength: 260 nm       
Fluoresence of 5d (333 nm)
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(viii) Fluorescence collected before and after 15 min of irradiation of 20d. Excitation 
wavelength: 333 nm  
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APPENDIX XI 
1H-NMR AND 13C-NMR SPECTRA OF 2-(2-CYANOPHENYL) ACETIC ACID 
(20) 
 
(Chapter -3) 
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